Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Sunday, March 25, 2012
Big Deal! Where's the hard end point data? Monthly shots of Amgen drug slash cholesterol 66 percent - South Florida Sun
One study with 51 patients and it's published in a newspaper? This is so wrong. I'm telling my neurologist that I don't want to hear about a single study, if it hasn't been replicated in a larger study. Failed tests should be reported too.
The pill that was being promoted to replace shots for people with MS killed two people in a trial recently and it had been hailed for over a year. I didn't get my hopes up because I've already decided I'm not going to take a drug before it's been unleashed for a few years and the unwanted effects become known.
It's irresponsible for these test results to be used to promote a drug before it has been thoroughly tested and approved. To hell with the stockholders! They are not entitled to make money from snake oil.
1 comment:
One study with 51 patients and it's published in a newspaper? This is so wrong. I'm telling my neurologist that I don't want to hear about a single study, if it hasn't been replicated in a larger study. Failed tests should be reported too.
The pill that was being promoted to replace shots for people with MS killed two people in a trial recently and it had been hailed for over a year. I didn't get my hopes up because I've already decided I'm not going to take a drug before it's been unleashed for a few years and the unwanted effects become known.
It's irresponsible for these test results to be used to promote a drug before it has been thoroughly tested and approved. To hell with the stockholders! They are not entitled to make money from snake oil.
Post a Comment